Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Möller

Showing results (11-20 of 656) with videos related to

Pageof 66
Sort By:
Journal of the Royal Society of Medicine|November 1, 1989
Efficacy of different strategies of aftercare for patients who have attempted suicideH J Möller
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Atypical neuroleptics: a new approach in the treatment of negative symptomsH J Möller
Journal of Clinical Psychopharmacology|December 10, 1999
Effectiveness and safety of benzodiazepinesH J Möller
Fortschritte Der Medizin|October 10, 1993
[Therapy of dementing diseases: value of calcium antagonists]H J Möller
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1995
The negative component in schizophreniaH J Möller
Der Nervenarzt|April 3, 2010
[Bipolar affective disorder]H-J Möller
MMW Fortschritte Der Medizin|November 21, 2002
[Detecting and treating suicidal risk patients: a challenge for the general practitioner]H J Möller
Der Nervenarzt|June 10, 2000
[Current assessment of new/atypical neuroleptic agents]H J Möller
International Clinical Psychopharmacology|June 1, 1994
Non-response to antidepressants: risk factors and therapeutic possibilitiesH J Möller
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1993
Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficultiesH J Möller
Pageof 66

Showing results (11-20 of 656) with videos related to

Sort By:
Pageof 66
Journal of the Royal Society of Medicine|November 1, 1989
Efficacy of different strategies of aftercare for patients who have attempted suicideH J Möller
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Atypical neuroleptics: a new approach in the treatment of negative symptomsH J Möller
Journal of Clinical Psychopharmacology|December 10, 1999
Effectiveness and safety of benzodiazepinesH J Möller
Fortschritte Der Medizin|October 10, 1993
[Therapy of dementing diseases: value of calcium antagonists]H J Möller
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1995
The negative component in schizophreniaH J Möller
Der Nervenarzt|April 3, 2010
[Bipolar affective disorder]H-J Möller
MMW Fortschritte Der Medizin|November 21, 2002
[Detecting and treating suicidal risk patients: a challenge for the general practitioner]H J Möller
Der Nervenarzt|June 10, 2000
[Current assessment of new/atypical neuroleptic agents]H J Möller
International Clinical Psychopharmacology|June 1, 1994
Non-response to antidepressants: risk factors and therapeutic possibilitiesH J Möller
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 1, 1993
Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficultiesH J Möller
Pageof 66